Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Long-term safety and continued clinical benefit of erenumab 70 mg in Asian patients with chronic migraine: an open-label extension of the phase 3 DRAGON study
Saved in:
| Published in: | Journal of Headache and Pain |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1868553996685279234 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Journal of Headache and Pain |
| description | |
| discipline_display | Anaesthesiology |
| discipline_facet | Anaesthesiology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:93459 |
| institution | FRELIP |
| journal_source_facet | Journal of Headache and Pain |
| last_indexed | 2026-06-20T21:45:54.952Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Long-term safety and continued clinical benefit of erenumab 70 mg in Asian patients with chronic migraine: an open-label extension of the phase 3 DRAGON study Anaesthesiology General Anaesthesiology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Anaesthesiology General Anaesthesiology |
| subject_facet | Anaesthesiology General Anaesthesiology |
| title | Long-term safety and continued clinical benefit of erenumab 70 mg in Asian patients with chronic migraine: an open-label extension of the phase 3 DRAGON study |
| title_alt | Seguridad a largo plazo y beneficio clínico continuo de erenumab 70 mg en pacientes asiáticos con migraña crónica: una extensión abierta del estudio de fase 3 DRAGON Sécurité à long terme et bénéfice clinique continu de l'érénumab 70 mg chez les patients asiatiques souffrant de migraine chronique : une extension en ouvert de l'étude de phase 3 DRAGON Segurança a longo prazo e benefício clínico contínuo de erenumab 70 mg em pacientes asiáticos com enxaqueca crônica: uma extensão aberta do estudo DRAGON fase 3 |
| title_auth | Long-term safety and continued clinical benefit of erenumab 70 mg in Asian patients with chronic migraine: an open-label extension of the phase 3 DRAGON study |
| title_es_txt | Seguridad a largo plazo y beneficio clínico continuo de erenumab 70 mg en pacientes asiáticos con migraña crónica: una extensión abierta del estudio de fase 3 DRAGON |
| title_fr_txt | Sécurité à long terme et bénéfice clinique continu de l'érénumab 70 mg chez les patients asiatiques souffrant de migraine chronique : une extension en ouvert de l'étude de phase 3 DRAGON |
| title_full | Long-term safety and continued clinical benefit of erenumab 70 mg in Asian patients with chronic migraine: an open-label extension of the phase 3 DRAGON study |
| title_fullStr | Long-term safety and continued clinical benefit of erenumab 70 mg in Asian patients with chronic migraine: an open-label extension of the phase 3 DRAGON study |
| title_full_unstemmed | Long-term safety and continued clinical benefit of erenumab 70 mg in Asian patients with chronic migraine: an open-label extension of the phase 3 DRAGON study |
| title_pt_txt | Segurança a longo prazo e benefício clínico contínuo de erenumab 70 mg em pacientes asiáticos com enxaqueca crônica: uma extensão aberta do estudo DRAGON fase 3 |
| title_short | Long-term safety and continued clinical benefit of erenumab 70 mg in Asian patients with chronic migraine: an open-label extension of the phase 3 DRAGON study |
| title_sort | long-term safety and continued clinical benefit of erenumab 70 mg in asian patients with chronic migraine: an open-label extension of the phase 3 dragon study |
| topic | Anaesthesiology General Anaesthesiology |
| url | https://link.springer.com/article/10.1186/s10194-026-02406-y |